ADCT ADC Therapeutics SA Common Shares
$0.98
价格 · 八月 25, 2026
截至...的财报数据 八月 13, 2026
52周区间
$1–$5
5% of range
分析师评级
STRONG BUY
12 analysts
目标价
$3
+240% upside
P/E (TTM)
-0.9
ROE
74.1%
净利润率
-175.3%
ADCT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.98
市值
$127M
P/E (TTM)
-0.9
每股收益 (TTM)
$-1.12
营收 (TTM)
$81M
股息收益率
—
ROE
74.1%
负债/权益
-0.0
52周区间
$1 – $5
ADCT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$81M
2022-12-31
→
2025-12-31
EPS
$-1.12
2022-12-31
→
2025-12-31
自由现金流
$-141M
2023-12-31
→
2025-12-31
利润率
-175.3%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ADCT
同行中位数
P/E (TTM)
-0.9
—
P/S (TTM) (市销率 (TTM))
1.6
26.5
P/B (市净率)
-0.7
5.6
EV / EBITDA (企业价值 / EBITDA)
1.1
—
Price / FCF (股价/自由现金流)
-0.9
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ADCT
同行中位数
Operating Margin (营业利润率)
-149.3%
—
Net Profit Margin (净利润率)
-175.3%
-980.9%
ROA
-44.2%
-47.5%
ROE
74.1%
-112.5%
ROIC
66.9%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ADCT
同行中位数
Debt / Equity (负债/股东权益比率)
-0.0
0.0
Current Ratio (流动比率)
4.4
3.4
Quick Ratio (速动比率)
3.7
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ADCT
同行中位数
Revenue YoY (营收同比增长)
14.8%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-27.1%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ADCT
同行中位数
ADCT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
12 位分析师
- 强烈买入 4 33.3%
- 买入 4 33.3%
- 持有 3 25.0%
- 卖出 0 0.0%
- 强烈卖出 1 8.3%
12个月价格目标
中位数
$3.00
平均值
$3.33
← 低于所有目标
$0.98
最低
$2.00
最高
$5.00
中位数目标
$3.00
+205.7%
平均目标
$3.33
+239.6%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.11%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.11 | $-0.22 | 0.11% |
| 2026年3月31日 | $-0.13 | $-0.22 | 0.09% |
| 2025年12月31日 | $-0.04 | $-0.27 | 0.23% |
| 2025年9月30日 | $-0.30 | $-0.37 | 0.07% |
| 2025年6月30日 | $-0.38 | $-0.48 | 0.10% |
| 2025年3月31日 | $-0.36 | $-0.41 | 0.05% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ADCT | $444M | -3.2 | 14.8% | -175.3% | 74.1% | — |
| ACIU | — | — | — | — | — | — |
| NCEL | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $81M | $71M | $70M | $210M | |
| Cost of Revenue | $6M | $6M | $3M | $3M | |
| R&D Expense | $104M | $110M | $127M | $186M | |
| SG&A Expense | $37M | $42M | $48M | $74M | |
| Operating Expenses | $203M | $201M | $236M | $333M | |
| Operating Income | $-121M | $-131M | $-166M | $-123M | |
| Interest Expense | · | $50M | $46M | $37M | |
| Interest Income | $9M | $12M | $11M | $3M | |
| Other Non-op | $23M | $12M | $6M | $53M | |
| Pretax Income | $-142M | $-156M | $-195M | $-147M | |
| Income Tax | $1M | $166.0K | $39M | $227.0K | |
| Net Income | $-143M | $-158M | $-240M | $-157M | |
| EPS (Basic) | $-1.12 | $-1.62 | $-2.94 | $-2.01 | |
| EPS (Diluted) | $-1.12 | $-1.62 | $-2.94 | $-2.01 | |
| Shares (Basic) | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | |
| Shares (Diluted) | 127,067,540 | 97,159,966 | 81,712,166 | 78,152,964 | |
| EBITDA | $-121M | $-131M | $-166M | · |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $261M | $251M | $279M | $326M | |
| Inventory | $4M | $2M | $16M | $12M | |
| Prepaid Expense | $6M | $8M | $10M | $23M | |
| Other Current Assets | $6M | $9M | $6M | · | |
| Current Assets | $306M | $291M | $336M | $435M | |
| PP&E (Net) | $0 | $5M | $6M | $3M | |
| PP&E (Gross) | $1M | $10M | $10M | $7M | |
| Accum. Depreciation | $1M | $5M | $4M | $3M | |
| Other Non-current Assets | $1M | $1M | $711.0K | $902.0K | |
| Total Assets | $323M | $322M | $355M | $491M | |
| Accounts Payable | $9M | $18M | $16M | $12M | |
| Accrued Liabilities | $58M | $62M | $52M | $68M | |
| Current Liabilities | $70M | $80M | $68M | $82M | |
| Capital Leases | $1M | $8M | $10M | $7M | |
| Deferred Tax | $789.0K | $2M | $1M | $4M | |
| Other Non-current Liabilities | $3M | $2M | $9M | $838.0K | |
| Total Liabilities | $509M | $525M | $503M | $411M | |
| Total Debt | $3M | · | · | · | |
| Common Stock | $11M | $8M | $7M | $7M | |
| Paid-in Capital | $1.44B | $1.28B | $1.18B | $1.17B | |
| Retained Earnings | $-1.64B | $-1.49B | $-1.34B | $-1.10B | |
| Treasury Stock | $205.0K | $220.0K | $541.0K | $679.0K | |
| AOCI | $-517.0K | $-1M | $-93.0K | $2M | |
| Stockholders' Equity | $-186M | $-203M | $-148M | $79M | |
| Liabilities + Equity | $323M | $322M | $355M | $491M | |
| Shares Outstanding | 125,748,762 | 101,606,376 | 89,041,946 | 89,041,946 |
现金流 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $7M | $7M | $13M | $49M | |
| Deferred Tax | $0 | $0 | $37M | $-2M | |
| Operating Cash Flow | $-141M | $-124M | $-119M | $-138M | |
| CapEx | $264.0K | $867.0K | $3M | $687.0K | |
| Investing Cash Flow | $395.0K | $-867.0K | $-3M | $-687.0K | |
| Stock Issued | $86M | $61M | $0 | · | |
| Net Stock Activity | $86M | $61M | · | · | |
| Financing Cash Flow | $151M | $97M | $74M | $-897.0K | |
| Taxes Paid | $-100.0K | $-900.0K | · | · | |
| Free Cash Flow | $-141M | $-125M | $-122M | · | |
| Levered FCF | · | $-175M | $-177M | · |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -149.3% | -184.4% | -238.6% | · | |
| Net Margin | -175.3% | -222.8% | -345.1% | · | |
| Pretax Margin | -174.1% | -220.4% | -280.9% | · | |
| EBITDA Margin | -149.3% | -184.4% | -238.6% | · | |
| ROA | -44.2% | -46.7% | -56.8% | · | |
| ROE | 74.1% | 84.3% | 225.9% | · | |
| ROIC | 66.9% | 64.5% | 134.4% | · |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 4.4 | 3.8 | 5.0 | · | |
| Quick Ratio | 3.7 | 3.1 | 4.1 | · | |
| Debt / Equity | -0.0 | · | · | · | |
| Interest Coverage | · | -2.6 | -3.6 | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | · | |
| Inventory Turnover | 1.8 | 0.3 | 0.2 | · |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 14.8% | 1.8% | -66.9% | · | |
| Revenue CAGR 3Y | -27.1% | · | · | · |
估值 (TTM) 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $81M | $71M | $70M | · | |
| Net Income TTM | $-143M | $-158M | $-240M | · | |
| Market Cap | $444M | $197M | $137M | · | |
| Enterprise Value | $186M | · | · | · | |
| P/E | -3.2 | -1.2 | -0.6 | · | |
| P/S | 5.5 | 2.8 | 2.0 | · | |
| P/B | -2.4 | -1.0 | -0.9 | · | |
| P / Cash Flow | -3.1 | -1.6 | -1.2 | · | |
| P / FCF | -3.1 | -1.6 | -1.1 | · | |
| EV / EBITDA | -1.5 | · | · | · | |
| EV / FCF | -1.3 | · | · | · | |
| EV / Revenue | 2.3 | · | · | · | |
| Earnings Yield | -31.7% | -81.4% | -177.1% | · |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $21M | $23M | $16M | $19M | $23M | $17M | $18M | $17M | $18M | $17M | $14M | $19M | $19M | |
| R&D Expense | $17M | $20M | $18M | $27M | $30M | $29M | $27M | $33M | $24M | $26M | $30M | $27M | $31M | $38M | |
| SG&A Expense | $10M | $10M | $9M | $8M | $9M | $10M | $10M | $10M | $10M | $12M | $11M | $10M | $12M | $16M | |
| Operating Expenses | $45M | $46M | $41M | $47M | $63M | $51M | $49M | $54M | $46M | $52M | $57M | $51M | $59M | $69M | |
| Operating Income | $-25M | $-25M | $-18M | $-31M | $-44M | $-28M | $-32M | $-36M | $-29M | $-34M | $-40M | $-36M | $-40M | $-50M | |
| Interest Expense | · | · | · | · | · | $12M | · | $13M | $13M | $12M | $13M | $13M | $10M | $10M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-op | $21M | $3M | $22M | $925.0K | $-182.0K | $203.0K | $11M | $2M | $3M | $-3M | $10M | $860.0K | $-5M | $833.0K | |
| Pretax Income | $-17M | $-33M | $-7M | $-41M | $-55M | $-38M | $-31M | $-44M | $-36M | $-46M | $-40M | $-45M | $-53M | $-57M | |
| Income Tax | $0 | $0 | $-404.0K | $0 | $1M | $165.0K | $-321.0K | $90.0K | $234.0K | $163.0K | $43M | $-85.0K | $-4M | $518.0K | |
| Net Income | $-17M | $-33M | $-6M | $-41M | $-57M | $-39M | $-31M | $-44M | $-37M | $-47M | $-85M | $-47M | $-49M | $-59M | |
| EPS (Basic) | $-0.11 | $-0.21 | $0.04 | $-0.30 | $-0.50 | $-0.36 | $-0.26 | $-0.42 | $-0.38 | $-0.56 | $-1.04 | $-0.57 | $-0.60 | $-0.73 | |
| EPS (Diluted) | $-0.11 | $-0.21 | $0.04 | $-0.30 | $-0.50 | $-0.36 | $-0.26 | $-0.42 | $-0.38 | $-0.56 | $-1.04 | $-0.57 | $-0.60 | $-0.73 | |
| Shares (Basic) | 155,016,023 | 154,142,347 | -230,324,726 | 136,446,534 | 113,743,358 | 107,202,374 | -185,908,478 | 104,824,877 | 95,691,245 | 82,552,322 | -162,821,578 | 82,256,847 | 81,471,127 | 80,805,770 | |
| Shares (Diluted) | 155,016,023 | 154,142,347 | -230,324,726 | 136,446,534 | 113,743,358 | 107,202,374 | -185,908,478 | 104,824,877 | 95,691,245 | 82,552,322 | -162,821,578 | 82,256,847 | 81,471,127 | 80,805,770 | |
| EBITDA | $-25M | $-25M | · | $-31M | $-44M | $-28M | · | $-36M | $-29M | $-34M | · | · | · | · |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $231M | $261M | $235M | $265M | $195M | $251M | $274M | $300M | $234M | $279M | · | · | · | |
| Inventory | $5M | $5M | $4M | $18M | $18M | $17M | $2M | $16M | $15M | $16M | $16M | · | · | · | |
| Prepaid Expense | $5M | $6M | $6M | $6M | $5M | $7M | $8M | $19M | $17M | $17M | $10M | · | · | · | |
| Other Current Assets | $4M | $4M | $6M | $6M | $6M | $7M | $9M | · | · | · | $6M | · | · | · | |
| Current Assets | $262M | $277M | $306M | $287M | $319M | $258M | $291M | $333M | $355M | $290M | $336M | · | · | · | |
| PP&E (Net) | · | · | $0 | $0 | $1.0K | $5M | $5M | $6M | $5M | $6M | $6M | · | · | · | |
| PP&E (Gross) | · | · | $1M | $6M | $6M | $11M | $10M | $11M | $10M | $10M | $10M | · | · | · | |
| Accum. Depreciation | · | · | $1M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $4M | · | · | · | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $986.0K | $711.0K | · | · | · | |
| Total Assets | $279M | $291M | $323M | $290M | $322M | $273M | $322M | $349M | $372M | $308M | $355M | · | · | · | |
| Accounts Payable | $13M | $5M | $9M | $8M | $10M | $16M | $18M | $14M | $11M | $14M | $16M | · | · | · | |
| Accrued Liabilities | $67M | $58M | $58M | $54M | $55M | $42M | $62M | $53M | $47M | $49M | $52M | · | · | · | |
| Current Liabilities | $86M | $68M | $70M | $62M | $65M | $58M | $80M | $68M | $58M | $63M | $68M | · | · | · | |
| Capital Leases | $946.0K | $991.0K | $1M | $1M | $1M | $8M | $8M | $9M | $9M | $10M | $10M | · | · | · | |
| Deferred Tax | · | · | $789.0K | · | · | · | $2M | · | · | · | $1M | · | · | · | |
| Other Non-current Liabilities | $6M | $5M | $3M | $9M | $7M | $4M | $2M | $8M | $7M | $7M | $9M | · | · | · | |
| Total Liabilities | $508M | $508M | $509M | $528M | $521M | $511M | $525M | $521M | $503M | $502M | $503M | · | · | · | |
| Total Debt | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $11M | $11M | $11M | $10M | $10M | $8M | $8M | $8M | $8M | $7M | $7M | · | · | · | |
| Paid-in Capital | $1.45B | $1.44B | $1.44B | $1.38B | $1.38B | $1.29B | $1.28B | $1.28B | $1.28B | $1.18B | $1.18B | · | · | · | |
| Retained Earnings | $-1.69B | $-1.67B | $-1.64B | $-1.63B | $-1.59B | $-1.53B | $-1.49B | $-1.46B | $-1.42B | $-1.38B | $-1.34B | · | · | · | |
| Treasury Stock | $205.0K | $205.0K | $205.0K | $205.0K | $207.0K | $207.0K | $220.0K | $222.0K | $239.0K | $502.0K | $541.0K | · | · | · | |
| AOCI | $-814.0K | $-802.0K | $-517.0K | $-702.0K | $-388.0K | $-1M | $-1M | $203.0K | $-338.0K | $-201.0K | $-93.0K | · | · | · | |
| Stockholders' Equity | $-228M | $-216M | $-186M | $-238M | $-199M | $-238M | $-203M | $-172M | $-132M | $-194M | $-148M | · | · | · | |
| Liabilities + Equity | $279M | $291M | $323M | $290M | $322M | $273M | $322M | $349M | $372M | $308M | $355M | · | · | · | |
| Shares Outstanding | 127,438,173 | 127,165,116 | 125,748,762 | 112,626,731 | 112,499,083 | 99,178,286 | 98,861,402 | 96,687,985 | 96,469,641 | 82,777,226 | 82,293,137 | · | · | · |
现金流 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $2M | $673.0K | $2M | $2M | $2M | $2M | $3M | $2M | $158.0K | $2M | $2M | $1M | $8M | |
| Operating Cash Flow | $-12M | $-30M | $-31M | $-30M | $-24M | $-56M | $-22M | $-25M | $-33M | $-44M | $-32M | $-37M | $-35M | $-15M | |
| CapEx | $0 | $32.0K | $0 | $0 | $0 | $264.0K | $90.0K | $216.0K | $30.0K | $531.0K | $327.0K | $661.0K | $1M | $1M | |
| Investing Cash Flow | $0 | $-32.0K | $659.0K | $0 | $0 | $-264.0K | $-90.0K | $-216.0K | $-30.0K | $-531.0K | $-327.0K | $-661.0K | $-1M | $-1M | |
| Stock Issued | $0 | $-20.0K | $44M | $-479.0K | $43M | $0 | $0 | $-1M | · | · | $0 | $0 | · | · | |
| Net Stock Activity | · | $-20.0K | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-99.0K | $-583.0K | $57M | $-198.0K | $94M | $271.0K | $-1M | $-879.0K | $99M | $356.0K | $-1.0K | $349.0K | $73M | $425.0K | |
| Free Cash Flow | · | $-30M | · | · | · | $-57M | · | · | · | $-45M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | $-69M | · | · | · | $-57M | · | · | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -132.0% | -121.1% | · | -188.5% | -234.3% | -123.6% | · | -192.6% | -166.8% | -186.2% | · | · | · | · | |
| Net Margin | -86.1% | -158.1% | · | -249.4% | -300.7% | -167.6% | · | -238.1% | -209.9% | -258.2% | · | · | · | · | |
| Pretax Margin | -86.1% | -158.1% | · | -249.4% | -294.0% | -166.9% | · | -236.2% | -205.1% | -253.4% | · | · | · | · | |
| EBITDA Margin | -132.0% | -121.1% | · | -188.5% | -234.3% | -123.6% | · | -192.6% | -166.8% | -186.2% | · | · | · | · | |
| ROA | -5.5% | -11.7% | · | -12.8% | -16.3% | -13.3% | · | -25.2% | -19.7% | -30.3% | · | · | · | · | |
| ROE | 7.8% | 14.5% | · | 20.0% | 34.2% | 17.8% | · | 51.1% | 55.5% | 47.9% | · | · | · | · | |
| ROIC | 11.5% | 11.9% | · | 13.0% | 22.7% | 12.0% | · | 20.7% | 22.2% | 17.3% | · | · | · | · |
流动性与偿付能力 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 4.1 | · | 4.6 | 4.9 | 4.5 | · | 4.9 | 6.2 | 4.6 | · | · | · | · | |
| Quick Ratio | 2.5 | 3.4 | · | 3.8 | 4.1 | 3.4 | · | 4.1 | 5.2 | 3.7 | · | · | · | · | |
| Debt / Equity | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | -2.3 | · | -2.7 | -2.3 | -2.7 | · | · | · | · |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · |
估值 (TTM) 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75M | $79M | · | $77M | $78M | $77M | · | $68M | $69M | $71M | · | · | · | · | |
| Net Income TTM | $-147M | $-169M | · | $-180M | $-176M | $-166M | · | $-174M | $-179M | $-202M | · | · | · | · | |
| Market Cap | $136M | $477M | · | $451M | $301M | $140M | · | $305M | $305M | $372M | · | · | · | · | |
| Enterprise Value | $-77M | $250M | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.0 | -2.7 | · | -2.5 | -1.6 | -0.8 | · | -1.6 | -1.5 | -1.8 | · | · | · | · | |
| P/S | 1.8 | 6.0 | · | 5.9 | 3.9 | 1.8 | · | 4.5 | 4.4 | 5.2 | · | · | · | · | |
| P/B | -0.6 | -2.2 | · | -1.9 | -1.5 | -0.6 | · | -1.8 | -2.3 | -1.9 | · | · | · | · | |
| P / Cash Flow | · | -16.1 | · | · | · | -2.5 | · | · | · | -8.4 | · | · | · | · | |
| P / FCF | · | -16.0 | · | · | · | -2.5 | · | · | · | -8.3 | · | · | · | · | |
| EV / EBITDA | 3.0 | -9.9 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -8.4 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | -1.0 | 3.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -104.7% | -36.5% | · | -39.5% | -61.9% | -122.0% | · | -61.3% | -66.8% | -54.8% | · | · | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 收入 | $81M | $71M | $70M | $210M |
| 营业利润率 % | -149.3% | -184.4% | -238.6% | — |
| 净收入 | $-143M | $-158M | $-240M | $-157M |
| 稀释后每股收益 (EPS) | $-1.12 | $-1.62 | $-2.94 | $-2.01 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 负债/股东权益比率 | -0.0 | — | — | — |
| 流动比率 | 4.4 | 3.8 | 5.0 | — |
| 速动比率 | 3.7 | 3.1 | 4.1 | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 自由现金流 | $-141M | $-125M | $-122M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 122 家申报者 · $74.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 28 (+5 与上一季度对比) | 30 (+18 与上一季度对比) | 39 (-10 与上一季度对比) | 28 (-1 与上一季度对比) | -4.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 11 位内幕人士 · 4 位高管 · 8 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Ameet Mallik | Chief Executive Officer | 2026年6月30日 A | 2121769 | 0 | 0 | $0 |
| Jose Carmona | Chief Financial Officer | 2026年6月30日 A | 938076 | 0 | 0 | $0 |
| Mohamed Zaki | Chief Medical Officer | 2026年6月30日 A | 896317 | 0 | 0 | $0 |
| Peter J Graham | Chief Legal Officer | 2026年6月30日 A | 841640 | 0 | 0 | $0 |
| Peter Hug | 董事 | 2026年6月3日 F | 263344 | 0 | 0 | $0 |
| Viviane Monges | 董事 | 2026年6月3日 F | 186447 | 0 | 0 | $0 |
| Robert Azelby | 董事 | 2026年6月3日 F | 112805 | 0 | 0 | $0 |
| Jean-Pierre Bizzari | 董事 | 2026年6月3日 F | 139302 | 0 | 0 | $0 |
| Victor Sandor | 董事 | 2026年6月3日 F | 140686 | 0 | 0 | $0 |
| Ron Squarer | 董事 | 2026年6月3日 F | 123431 | 0 | 0 | $0 |
| Timothy Coughlin | 董事 | 2026年6月3日 F | 72400 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| A.T. Holdings II Sarl, C.T. Phinco Sarl, ADC Products Switzerland Sarl, Auven Therapeutics Holdings L.P., Auven Therapeutics General L.P., Auven Therapeutics GP Ltd., Stephen Evans-Freke, Peter B. Corr ×8 申报 | 2024年4月25日 | — | 初始申报 | — | SEC |
| HPWH TH AG, HP WILD HOLDING AG, Dr. Hans-Peter Wild, Thomas Pfisterer | 2020年9月14日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 12 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.02% | 365133 SH | 2026年8月21日 | 每日 |
| RSSL · Global X Funds | 0.01% | 44238 NS | 2026年4月30日 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 74478 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.01% | 703942 SH | 2026年8月21日 | 每日 |
| IWN · iShares Trust | 0.00% | 714774 SH | 2026年8月21日 | 每日 |
| IWM · iShares Trust | 0.00% | 2695006 SH | 2026年8月21日 | 每日 |
| IWO · iShares Trust | 0.00% | 202930 SH | 2026年8月21日 | 每日 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2526 NS | 2026年5月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 47769 SH | 2026年8月21日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.00% | 611978 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 24289 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9269 SH | 2026年8月19日 | 每日 |